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Cryopreservation allows for the long-term storage of CBC. DMSO is the most frequently used cryopreservation agent. 2 However, the use of DMSO has been reported to induce complications ranging from nausea, vomiting, abdominal pain to life-threatening cardiac arrhythmias or cardiopulmonary events, 3 after infusion of cryopreserved BM or peripheral HSC.
We report here on a 60-year-old patient having been treated in our department for an atypical chronic myeloid leukemia, bcr/abl negative, with trisomy 8, which was diagnosed in 2003 /kg CD34 þ cells and 3.03 Â 10 4 /kg CFU-GM. RBCs have not been depleted before cryopreservation and the product haematocrit was 12.2%. Microbiological controls were negative. The graft was stored in liquid nitrogen in the presence of 10% DMSO, according to the protocol of Rubinstein et al. 5 On the day of transplantation, the bag was thawed in a 371C waterbath. The cryopreservation solution was removed by centrifugation and cells were suspended in a final volume of 175 ml with 4% albumin. Graft was given to the patient at a rate of 15 ml/min through a central venous catheter.
Fifteen minutes after the onset of the transfusion, the patient presented severe abdominal pain, nausea and vomiting, hypertension (180/110 mm Hg) and hypothermia (351C). Oxygen saturation was 90%. The electrocardiogram showed ST-segment elevation at V1, V2, V3 and V4 leads and slight ST-segment depression at V5 and V6 leads (Figure 1a) . Troponin was slightly elevated (0.9 mg/l), whereas myoglobin and creatine kinase were within normal values. The patient was relieved after the inhalation of nitroglycerin and the administration of aspirin (1000 mg p.o.), morphine (20 mg i.v.) and nasal O 2 (2 l/min). After the acute phase, nitroglycerin was administered in continuous i.v. infusion of 1 mg/h for 24 consecutive hours. A coronography was urgently effectuated. No arterial occlusion was observed. The echocardiography revealed a slight atrial hypokinesia. The following day, the electrocardiogram showed inverted, deep T-waves at V2, V3, V4, V5 and V6 leads (Figure 1b) . Three days later, the electrocardiogram was normalized. The episode was attributed to coronary artery spasm. The patient died several weeks after the transplantation from multiorgan failure.
Cardiovascular side effects, such as sinus bradycardia, transient heart blocks or even fatal cardiopulmonary events, have been reported after infusion of cryopreserved HSC. 3, [6] [7] [8] Nevertheless, the pathogenesis of the aforementioned complications is not clear and is supposed to be multi-factorial. Apart from DMSO toxicity, other factors such as cell lysis' products, 3 toxicity related to previous treatments or conditioning regimens, 9 hypothermia of the infused cells or acute volume expansion, 6 have been implicated in the pathogenesis of cardiovascular complications following the infusion of cryopreserved HSC. Such complications have been usually observed after administration of HSC when thawing without washing procedure. Recently, a French team reported severe neurological accidents after PBSC transplantation related to the number of polymorphonuclear cells in the graft and to high administration rate (F Norol, personal communication). This is the first report of the occurrence of a coronary spasm after the infusion of cryopreserved HSC and, more interestingly, after the infusion of CBC. It seems difficult to directly implicate DMSO in the occurrence of the coronary spasm as the cryopreservation solution was removed by centrifugation. High viscosity due to RBC contamination could possibly be involved. The age of the patient, the toxicity of previous chemotherapies or of the conditioning regimen, are other possible concomitant factors. However, pre-transplant echocardiographic evaluation showed normal left-ventricular systolic function (ejection fraction ¼ 60%), while the left-ventricular end-diastolic pressure, the diastolic function and the pulmonary pressures were also normal. Acute volume expansion does not seem a contributing factor, as total infused volume was only 175 ml. On the day of the transplantation, the patient presented slight electrolyte abnormalities with normal renal function (Na þ ¼ 130 mmol/l, K þ ¼ 5, 1 mmol/l, urea ¼ 9 mmol/l, creatinine ¼ 75 mmol/l) and normal C-reactive protein (CRP ¼ 4 mg/l), which cannot easily provoke vagal responses, such as a coronary spasm.
The use of CBC in a variety of non-haematological disorders is currently being investigated and is considered to be a new promising treatment especially in cardiovascular diseases. 10 However, this report of the occurrence of a coronary spasm during infusion of CBC should be taken into account for future investigations considering the therapeutic potential of CBC in the reparation of the impaired myocardium. 
